RecruitingNCT07015580

The Characteristics of Oral Microbiota in Chronic Pancreatitis and Autoimmune Pancreatitis


Sponsor

Ruijin Hospital

Enrollment

360 participants

Start Date

Feb 18, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

There are more than 700 different bacteria colonized in human oral cavity, which are collectively referred to as oral microbiota. Emerging evidence suggests that oral microbiota plays a series of important roles in human health, such as immune response, carcinogen metabolism and nutrient digestion. The changes of oral microbiota composition are closely related to the occurrence and development of pancreatic diseases. Previous studies have found that there are dense bacterial biofilms in the pancreatic duct of patients with calcified pancreatitis, including oral bacterial types. However, most studies only focused on the changes of gut microbiota in patients with chronic pancreatitis, and there were lack of research and description on the changes of oral microbiota in patients with chronic pancreatitis. In this study, we will extract and sequence bacterie's full-length 16S rRNA to describe the characteristics of oral microbiota in patients with chronic pancreatitis, confirming that there are changes in oral microbiota in patients with chronic pancreatitis, and compare the differences of oral microbiota in patients with chronic pancreatitis, pancreatic cancer and autoimmune pancreatitis.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This observational study is collecting saliva samples to study the types of bacteria living in the mouth (oral microbiota) of people with chronic pancreatitis (long-term pancreatic inflammation) or autoimmune pancreatitis, to learn whether these bacteria are linked to the disease. **You may be eligible if...** - You have been diagnosed with chronic pancreatitis or autoimmune pancreatitis - You are able to provide a saliva or oral sample - You agree to participate **You may NOT be eligible if...** - You have had prior digestive system surgery - You are currently pregnant or breastfeeding - You have an infectious disease, cancer, or another digestive condition (such as inflammatory bowel disease) - You have taken antibiotics or immunosuppressive drugs in the past 30 days - You take daily probiotic supplements Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHER16S rRNA sequencing

Clinical data including medical history, clinical symptoms, imaging examination, laboratory examination will be collected. 3-5ml saliva sample of every patients will be collected for 16S rRNA sequencing of oral microbiota.


Locations(1)

Department of Gastroenterolog, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine

Shanghai, Shanghai, China, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07015580


Related Trials